Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam

Objective: To assess levels of HBsAb amongst infants who received hepatitis B vaccine in the Expanded Program on Immunization in Vietnam. Methods: A cross-sectional study was carried out at 16 community health centers from February 2016 to July 2017. Eligible infants were tested for HBsAb and HBsAg....

Full description

Bibliographic Details
Published in:Asian Pacific Journal of Tropical Medicine
Main Authors: Giao Huynh, Quang Vinh Bui, Ngoc Lan Nguyen, Le An Pham
Format: Article in Journal/Newspaper
Language:English
Published: Wolters Kluwer Medknow Publications 2020
Subjects:
Online Access:https://doi.org/10.4103/1995-7645.285828
https://doaj.org/article/e5d989a9552e40ae8a61568faac766ef
id ftdoajarticles:oai:doaj.org/article:e5d989a9552e40ae8a61568faac766ef
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:e5d989a9552e40ae8a61568faac766ef 2023-05-15T15:11:43+02:00 Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam Giao Huynh Quang Vinh Bui Ngoc Lan Nguyen Le An Pham 2020-01-01T00:00:00Z https://doi.org/10.4103/1995-7645.285828 https://doaj.org/article/e5d989a9552e40ae8a61568faac766ef EN eng Wolters Kluwer Medknow Publications http://www.apjtm.org/article.asp?issn=1995-7645;year=2020;volume=13;issue=7;spage=295;epage=300;aulast=Huynh https://doaj.org/toc/2352-4146 2352-4146 doi:10.4103/1995-7645.285828 https://doaj.org/article/e5d989a9552e40ae8a61568faac766ef Asian Pacific Journal of Tropical Medicine, Vol 13, Iss 7, Pp 295-300 (2020) hepatitis b virus hepatitis b vaccine vaccination expanded program on immunization Arctic medicine. Tropical medicine RC955-962 article 2020 ftdoajarticles https://doi.org/10.4103/1995-7645.285828 2022-12-31T05:14:31Z Objective: To assess levels of HBsAb amongst infants who received hepatitis B vaccine in the Expanded Program on Immunization in Vietnam. Methods: A cross-sectional study was carried out at 16 community health centers from February 2016 to July 2017. Eligible infants were tested for HBsAb and HBsAg. Structured questionnaires were used to collect relevant information about the demographics of the parents/caregivers and their infants after physical examination. Results: A total of 199 eligible infants were selected with a mean age of (17.3±4.5) months. Protective antibody levels with HBsAb ≥10 mIU/mL were detected in 68.3% of infants. Of these, antibody levels from 10 to 99 mIU/ mL were 48.5% of those tested and antibody levels ≥100 mlU/mL were recorded as 51.5%. No cases were recorded of being infected with hepatitis B virus. The rate of positive HBsAb level in those who were not wasting and 18 months old was less than that among those who were <18 months old (OR 0.49, 95% CI: 0.26-0.92, P<0.05) while the infants with wasting and <18 months were less likely to be positive HBsAb than those who were not wasting and of the same age group (OR 0.15, 95% CI: 0.04-0.55, P<0.05). Conclusions: Seroprotection against hepatitis B virus was low in the infants tested (at 68.3%), which suggests that the hepatitis B vaccine should be administered with one additional dose for infants between 12 and 24 months of age, particularly those with wasting. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Asian Pacific Journal of Tropical Medicine 13 7 295
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic hepatitis b virus
hepatitis b
vaccine
vaccination
expanded program on immunization
Arctic medicine. Tropical medicine
RC955-962
spellingShingle hepatitis b virus
hepatitis b
vaccine
vaccination
expanded program on immunization
Arctic medicine. Tropical medicine
RC955-962
Giao Huynh
Quang Vinh Bui
Ngoc Lan Nguyen
Le An Pham
Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam
topic_facet hepatitis b virus
hepatitis b
vaccine
vaccination
expanded program on immunization
Arctic medicine. Tropical medicine
RC955-962
description Objective: To assess levels of HBsAb amongst infants who received hepatitis B vaccine in the Expanded Program on Immunization in Vietnam. Methods: A cross-sectional study was carried out at 16 community health centers from February 2016 to July 2017. Eligible infants were tested for HBsAb and HBsAg. Structured questionnaires were used to collect relevant information about the demographics of the parents/caregivers and their infants after physical examination. Results: A total of 199 eligible infants were selected with a mean age of (17.3±4.5) months. Protective antibody levels with HBsAb ≥10 mIU/mL were detected in 68.3% of infants. Of these, antibody levels from 10 to 99 mIU/ mL were 48.5% of those tested and antibody levels ≥100 mlU/mL were recorded as 51.5%. No cases were recorded of being infected with hepatitis B virus. The rate of positive HBsAb level in those who were not wasting and 18 months old was less than that among those who were <18 months old (OR 0.49, 95% CI: 0.26-0.92, P<0.05) while the infants with wasting and <18 months were less likely to be positive HBsAb than those who were not wasting and of the same age group (OR 0.15, 95% CI: 0.04-0.55, P<0.05). Conclusions: Seroprotection against hepatitis B virus was low in the infants tested (at 68.3%), which suggests that the hepatitis B vaccine should be administered with one additional dose for infants between 12 and 24 months of age, particularly those with wasting.
format Article in Journal/Newspaper
author Giao Huynh
Quang Vinh Bui
Ngoc Lan Nguyen
Le An Pham
author_facet Giao Huynh
Quang Vinh Bui
Ngoc Lan Nguyen
Le An Pham
author_sort Giao Huynh
title Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam
title_short Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam
title_full Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam
title_fullStr Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam
title_full_unstemmed Seroprotection after hepatitis B vaccination amongst infants aged between 12 and 24 months in Ho Chi Minh City, Vietnam
title_sort seroprotection after hepatitis b vaccination amongst infants aged between 12 and 24 months in ho chi minh city, vietnam
publisher Wolters Kluwer Medknow Publications
publishDate 2020
url https://doi.org/10.4103/1995-7645.285828
https://doaj.org/article/e5d989a9552e40ae8a61568faac766ef
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Asian Pacific Journal of Tropical Medicine, Vol 13, Iss 7, Pp 295-300 (2020)
op_relation http://www.apjtm.org/article.asp?issn=1995-7645;year=2020;volume=13;issue=7;spage=295;epage=300;aulast=Huynh
https://doaj.org/toc/2352-4146
2352-4146
doi:10.4103/1995-7645.285828
https://doaj.org/article/e5d989a9552e40ae8a61568faac766ef
op_doi https://doi.org/10.4103/1995-7645.285828
container_title Asian Pacific Journal of Tropical Medicine
container_volume 13
container_issue 7
container_start_page 295
_version_ 1766342535022641152